This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Imdpharm Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Sang-won Jeon
Introduction
Sang-won Jeon is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release formulations. His innovative work has led to the creation of a unique lipid preformulation that enhances the delivery of pharmacologically active substances.
Latest Patents
Sang-won Jeon holds 1 patent for his invention titled "Sustained-release lipid preformulation and pharmaceutical composition for sustained-release injection in form of lipid solution containing same." This patent describes a sustained-release lipid pre-concentrate that includes an unsaturated fatty acid with 14 to 20 carbon atoms, a phospholipid, and α-tocopherol acetate. The formulation is designed to be free of diacyl glycerol and sorbitan unsaturated fatty acid ester, forming a liquid crystal in an aqueous medium. Additionally, the injectable pharmaceutical composition derived from this pre-concentrate is also free of these compounds, ensuring a more effective delivery system.
Career Highlights
Sang-won Jeon is currently associated with Imdpharm Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug delivery systems, which is crucial for enhancing patient outcomes. His expertise in lipid formulations has positioned him as a valuable asset in his field.
Collaborations
Throughout his career, Sang-won Jeon has collaborated with talented individuals such as Young-Joon Park and Sook Choi. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Sang-won Jeon's contributions to the field of pharmaceuticals through his innovative lipid preformulation highlight his commitment to advancing drug delivery technologies. His work not only showcases his inventive spirit but also emphasizes the importance of collaboration in achieving significant advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile